Targeting and Safety Monitoring for LIFUP in First Human Trials Alexander Korb, PhD Mentor: Alexander Bystritsky, M.D., Ph.D.
Chronic Inflammatory Demyelinating Polyneuropathy By: Kyle Leato, SPTA.
By Tiffany Steele, SPTA. 1. Cardiovascular Disease (CVD) statistics 2. Pathophysiological conditions that underlie CVD 3. The effects of selected.
